Peroxisome Proliferator-Activated Receptor (PPAR): Balance for survival in parasitic infections

Marion M. Chan, Kyle W. Evans, Andrea R. Moore, Dunne Fong

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Parasitic infections induce a magnitude of host responses. At the opposite ends of the spectrum are those that ensure the host's needs to eliminate the invaders and to minimize damage to its own tissues. This review analyzes how parasites would manipulate immunity by activating the immunosuppressive nuclear factor, peroxisome proliferator-activated receptors (PPARs) with type 2 cytokines and free fatty acids from arachidonic acid metabolism. PPARs limit the action of type 1 immunity, in which classically activated macrophages act through the production of proinflammatory signals, to spare the parasites. They also favor the development of alternately activated macrophages which control inflammation so the host would not be destroyed. Possibly, the nuclear factors hold a pivotal role in the establishment of chronic infection by delicately balancing the pro-and anti-inflammatory signaling mechanisms and their ligands may be used as combination therapeutics to limit host pathology.

Original languageEnglish (US)
Article number828951
JournalJournal of Biomedicine and Biotechnology
StatePublished - 2010

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Health, Toxicology and Mutagenesis


Dive into the research topics of 'Peroxisome Proliferator-Activated Receptor (PPAR): Balance for survival in parasitic infections'. Together they form a unique fingerprint.

Cite this